|
PRRG4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.100830E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.824500E-04 |
| Normal-vs-Stage2 |
8.608000E-01 |
| Normal-vs-Stage3 |
4.896500E-02 |
| Normal-vs-Stage4 |
9.944400E-03 |
| Stage1-vs-Stage2 |
3.759600E-02 |
| Stage1-vs-Stage3 |
6.746800E-01 |
| Stage1-vs-Stage4 |
4.321800E-01 |
| Stage2-vs-Stage3 |
1.464180E-01 |
| Stage2-vs-Stage4 |
3.541800E-02 |
| Stage3-vs-Stage4 |
3.877600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.647900E-04 |
| Normal-vs-AfricanAmerican |
8.076000E-02 |
| Normal-vs-Asian |
2.343000E-01 |
| Caucasian-vs-AfricanAmerican |
9.083800E-01 |
| Caucasian-vs-Asian |
2.952400E-01 |
| AfricanAmerican-vs-Asian |
4.024600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.141200E-03 |
| Normal-vs-Female |
3.517700E-03 |
| Male-vs-Female |
4.276200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.05109999999298E-05 |
| Normal-vs-Age(41-60Yrs) |
5.904100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.502420E-01 |
| Normal-vs-Age(81-100Yrs) |
8.838400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.967500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.292500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.543570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.222800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.031400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.159600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.884600E-01 |
| Classical-VS-Follicular |
3.528200E-02 |
| Classical-VS-Other |
6.452400E-01 |
| Classical-VS-Normal |
7.63880000000938E-05 |
| Tall-VS-Follicular |
3.470200E-01 |
| Tall-VS-Other |
8.209800E-01 |
| Tall-VS-Normal |
8.097600E-02 |
| Follicular-VS-Other |
7.689200E-01 |
| Follicular-VS-Normal |
4.996400E-01 |
| Other-VS-Normal |
6.239800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.976300E-02 |
| Normal-vs-N1 |
1.950080E-02 |
| N0-vs-N1 |
3.145800E-01 |
|
|
